Abstract
Background: Primary small intestinal lymphoma (PSIL) constitutes 15%-20% of all small intestine neoplasms and 20%-30% of all primary gastrointestinal lymphomas. The aim of this study was to retrospectively analyze clinicopathological features and survival response data in patients with PSIL.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
